According to research published in the British Journal of Sports Medicine, IV rehydration has been proposed as an ergogenic aid for athletes to achieve euhydration more effectively than oral routes
Protect from excessive heat, freezing temperatures, and direct light
Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance
Researchers can mix the powder with a suitable liquid to prepare it for their experiments
Non-Impact on Hormonal Levels: Unlike other peptides, AOD-9604 does not affect IGF-1 levels, making it a safer option for metabolic support
